Menu

Get in the Game: Primary Cell Thawing Made Easy

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; -webkit-text-stroke: #000000} span.s1 {font-kerning: none} Learn how to thaw your primary cells right the first time, and avoid common mistakes that cause poor cell survival, requiring you to start over, in this ZenBio poster. 

Nov 30, 2016
The Scientist Creative Services Team

Thawing can be a stressful process for frozen primary cells. Learn how to thaw your primary cells right the first time, and avoid common mistakes that cause poor cell survival, requiring you to start over. 

ZenBio is committed to being your research partner. Since its inception in 1995, ZenBio has been a recognized leader in the development and manufacture of advanced cell-based research products and services. Our expertise is reflected in our commitment to collaboration and world-class technical support. We take our customers' research needs seriously, and we strive to provide the highest quality products and services within everyone's reach. Our modest and tightly controlled balance sheet allows us to keep costs down for you. 

ZenBio believes that researchers have more important work at hand than struggling with procuring tissue and isolating cells. Since the beginning, we have worked to establish a robust tissue procurement network and best-in-class cell isolation technologies to simplify research on primary cell systems. Our tissue collection and cell isolation procedures are all institutional review board (IRB) approved, and we have a rigorous quality control system that ensures that only the highest quality cells and media are shipped to our customers.

We're always developing new cell systems to meet your research needs, so please let us know what you're looking for. We're happy to add it to our development pipeline. 

Download this poster from The Scientist, sponsored by ZenBio to learn more!

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.